In line with the in vitro findings, we observed that TRIM6 overexpression promoted, while TRIM6 knockdown further inhibited tumor growth upon DDP or PTX chemotherapy (Figures 6(e)–6(h)). The gene discussed is TRIM6; the disease is neoplasm.